sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Intravenous (IV) Ibuprofen Market by Indication (Pain/Inflammatory, Fever) and Age Group (Pediatrics, Adults) - Global Opportunity Analysis and Industry Forecast, 2015 - 2022

Intravenous (IV) Ibuprofen Market by Indication (Pain/Inflammatory, Fever) and Age...

Home / Categories / Healthcare
Intravenous (IV) Ibuprofen Market by Indication (Pain/Inflammatory, Fever) and Age Group (Pediatrics, Adults) - Global Opportunity Analysis and Industry Forecast, 2015 - 2022
Intravenous (IV) Ibuprofen Market by...
Report Code
RO1/113/1036

Publish Date
01/Apr/2016

Pages
65
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2027

2.2.1 Moderate scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis
3.4 Government regulations
3.5 Research & Analysis

3.5.1 Clinical trials

3.6 Market dynamics

3.6.1 Drivers
3.6.2 Restraints
3.6.3 Opportunities

CHAPTER 4 WORLD ANALGESICS MARKET, BY AGE GROUP, 2015-2022

4.1 Pediatrics

4.1.1 Market size and forecast

4.2 Adults

4.2.1 Market size and forecast

CHAPTER 5 WORLD ANALGESICS MARKET, BY INDICATION, 2015-2022

5.1 Pain

5.1.1 Market size and forecast

5.2 Fever

5.2.1 Market size and forecast

CHAPTER 6 WORLD ANALGESICS MARKET, BY COUNTRY, 2015-2022

6.1 Market size and forecast for IV ibuprofen
6.2 United States

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast for actual IV ibuprofen

6.3 Canada

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast for actual IV ibuprofen

6.4 Australia

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast for actual IV ibuprofen

6.5 South Korea

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast for actual IV ibuprofen

CHAPTER 7 COMPANY PROFILES

7.1 Cumberland Pharmaceuticals Inc.

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Business performance
7.1.5 Key strategic moves and developments
7.1.6 SWOT analysis

7.2 Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.)

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Business performance
7.2.5 Key strategic moves and developments
7.2.6 SWOT analysis

7.3 CSL Limited

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key strategic moves and developments
7.3.6 SWOT analysis

7.4 Sandor Medicaids Pvt Ltd.

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Business performance
7.4.5 Key strategic moves and developments
7.4.6 SWOT analysis

7.5 PT. Soho Industri Pharmasi

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key strategic moves and developments
7.5.6 SWOT analysis

7.6 Germin MED

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Business performance
7.6.5 Key strategic moves and developments
7.6.6 SWOT analysis

7.7 Grifols S.A.

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key strategic moves and developments
7.7.6 SWOT analysis

7.8 Harbin Gloria Pharmaceuticals Co., Ltd.

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key strategic moves and developments
7.8.6 SWOT analysis

7.9 Al Nabeel International Ltd.

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key strategic moves and developments
7.9.6 SWOT analysis

7.10 Laboratorios Valmorca, C.A.

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Business performance
7.10.5 Key strategic moves and developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com